临床肝胆病杂志2018，Vol.34Issue(2)：410-413,4.DOI:10.3969/j.issn.1001-5256.2018.02.043
丙型肝炎直接抗病毒治疗与肝癌发生及复发的关系
Association of direct-acting antiviral therapy for hepatitis C with the development and recurrence of liver cancer
李砚 1刘蕾 2罗书兰 3罗超 1汤善宏3
作者信息
- 1. 中国人民解放军第四十二医院感染科,四川乐山614000
- 2. 成都市第三人民医院医学实验部,成都610000
- 3. 成都军区总医院消化科,成都610000
- 折叠
摘要
Abstract
Chronic hepatitis caused by hepatitis C virus (HCV) infection is one of the leading causes of liver cirrhosis and hepatocellular carcinoma.In recent years,direct-acting antiviral agents (DAAs) have gradually become main drugs for the treatment of hepatitis C.Studies have shown that DAAs may increase the risk of the development or recurrence of liver cancer in patients with HCV-related liver cirrhosis,which causes great controversies over the clinical application of DAAs.This article reviews the influence of DAAs on the development and recurrence of liver cancer,in order to provide a better basis for the clinical application of DAAs.关键词
肝炎,丙型/癌,肝细胞/抗病毒药/综述Key words
hepatitis C/carcinoma, hepatocellular/antiviral agents/review分类
医药卫生引用本文复制引用
李砚,刘蕾,罗书兰,罗超,汤善宏..丙型肝炎直接抗病毒治疗与肝癌发生及复发的关系[J].临床肝胆病杂志,2018,34(2):410-413,4.
